Cvs Health dividend calculator – CVS Health Declares Quarterly Dividend of $0.605 with a Forward Yield of 2.76%
January 30, 2023
Trending News 🌥️
Cvs Health dividend calculator – CVS ($NYSE:CVS) Health, a leading pharmacy innovation company, announced on Thursday that it will pay a quarterly dividend of $0.605 to its shareholders. This dividend is in accordance with their previous dividend and has a forward yield of 2.76%. This dividend payment will be payable on February 1st to shareholders of record on January 20th, and the ex-dividend date is January 19th. Investors can find this information on Seeking Alpha’s dividend scorecard for CVS. It is a leader in the industry, providing a range of services including pharmacy benefit management, specialty pharmacy care, retail pharmacy and mail order pharmacy services.
CVS Health also offers health care services such as MinuteClinic and Omnicare. Its retail stores offer products and services that support healthy living, including over-the-counter medications, vitamins, supplements, home health care supplies, and personal care products. CVS Health’s stock has performed well over the past several years and has seen steady growth in its stock price. The company has a strong balance sheet and is well-positioned to take advantage of opportunities in the rapidly changing health care market. This dividend payment marks the company’s commitment to return value to its shareholders.
Dividends – Cvs Health dividend calculator
This is a notable increase from the annual dividend per share of 2.15, 2.0 and 2.0 USD in the last 3 years respectively. This is a solid indicator that the company is doing well and is capable of paying dividends consistently. The average dividend yield over this period is 2.65%. This makes CVS Health an attractive proposition for investors who are looking for stocks with reliable dividend yields. The quarterly dividend payment is a sign of the company’s financial health and its commitment to rewarding shareholders.
It is also an indication that the company’s outlook is positive and that it has the capacity to generate profits in the long-term. Furthermore, CVS Health’s dividend yield is higher than the average for large-cap stocks, making it a worthwhile investment for those seeking a reliable source of income. In short, if you are looking for dividend stocks, CVS Health might be worth considering. Not only does it offer a reliable stream of income, but its dividend yields are also attractive and its outlook is positive.
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Cvs Health. More…
| Total Revenues | Net Income | Net Margin |
| 315.23k | 3.15k | 3.4% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Cvs Health. More…
| Operations | Investing | Financing |
| 22.13k | -6.37k | -11.24k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Cvs Health. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 231.21k | 160.2k | 53.75 |
Key Ratios Snapshot
Some of the financial key ratios for Cvs Health are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 8.9% | 9.9% | 2.0% |
| FCF Margin | ROE | ROA |
| 6.2% | 5.5% | 1.7% |
Stock Price
This news did not seem to have a positive impact on the market, as news sentiment regarding the company has been mostly negative. On Thursday, CVS Health stock opened at $87.7 and closed at $87.5, down by 0.8% from the prior closing price of 88.2. This was the third consecutive day that CVS Health stock had declined in value, continuing a downward trend that began on Tuesday. The news of the dividend payout from CVS Health appears to have had a limited impact on the stock price, possibly due to the overall negative sentiment around the company’s stock. Investors may be hesitant to invest in CVS Health given the recent decline in its stock price as well as concerns about its future prospects.
However, investors may find the dividend yield attractive enough to consider investing in CVS Health despite the negative sentiment surrounding it. Live Quote…
VI Analysis
CVS Health is a healthcare company with a long-term potential that can be assessed from its fundamentals. The VI App provides a simplified analysis of the company’s risk rating, which is considered to be medium. This rating takes into consideration the financial and business aspects of the company. The VI App has detected three risk warnings in the income sheet, balance sheet and non-financial areas. The income sheet warning is related to the company’s ability to generate income from its operations. The balance sheet warning is related to the company’s assets and liabilities and the non-financial warning is related to the company’s business strategies and practices. Investors should consider these risk warnings before investing in CVS Health. The company’s financial performance, business strategies and practices should all be reviewed to assess its potential for long-term growth. The VI App can help investors make an informed decision based on their analysis of the company’s fundamentals. Registering on the app will provide more detailed information about CVS Health’s risk rating and the three risk warnings. More…
VI Peers
The competition between CVS Health Corp and its competitors is fierce. Each company is striving to be the top provider of healthcare services and products. CVS Health Corp is the largest provider of pharmacy services in the United States. Marpai Inc is a close second. Molina Healthcare Inc and Humana Inc are also major competitors in the healthcare industry.
– Marpai Inc ($NASDAQ:MRAI)
Marpai Inc is a publicly traded company with a market capitalization of 20.89 million as of 2022. The company has a return on equity of -64.66%. Marpai Inc is engaged in the business of developing and marketing products and services for the energy industry. The company’s products and services include oil and gas exploration, production, and development; oilfield services; and petrochemical refining.
– Molina Healthcare Inc ($NYSE:MOH)
Molina Healthcare Inc is a health care company that provides Medicaid-related solutions for low-income families and individuals. As of 2022, the company had a market capitalization of 20.52 billion dollars and a return on equity of 24.89%. The company’s main business is providing managed care services under the Medicaid and Medicare programs. In addition to this, the company also provides other health services such as behavioral health, long-term care, and pharmacy services.
– Humana Inc ($NYSE:HUM)
Humana Inc is a healthcare company that offers a wide range of health and wellness products and services. The company has a market cap of 63.3B as of 2022 and a return on equity of 17.4%. Humana’s products and services include medical and prescription drug coverage, dental and vision coverage, and wellness and fitness programs. The company also offers a variety of health and wellness products and services for individuals, families, and businesses.
Summary
Investing in CVS Health can be a wise decision for those seeking to diversify their portfolio. With a forward yield of 2.76%, CVS Health offers an attractive dividend payout. The company has seen a consistent increase in its stock price over the past few years, which makes it an appealing long-term option for investors.
In addition, CVS Health has a strong balance sheet and is well-positioned to benefit from potential growth opportunities in the coming years. As such, investors should consider buying into CVS Health if they are looking to add a dividend-paying stock to their portfolio.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
